Original Article
Author Details :
Volume : 8, Issue : 3, Year : 2022
Article Page : 147-151
https://doi.org/10.18231/j.ijced.2022.032
Abstract
Background: Autoimmune urticaria (AIU) is an important subset of chronic spontaneous urticaria (CSU) and can be relatively difficult to manage. Autologous serum skin test (ASST) has served as a useful bedside test to detect AIU and its comparison with various blood biomarkers may unlock avenues in diagnosing autoimmune urticaria.
Objective: Aim of our study was to assess role of ASST in CSU and its correlation with relevant biomarkers.
Materials and Methods: It was a hospital-based study in which 58 patients were enrolled. ASST was done in all with routine investigations including Absolute Eosinophil Count (AEC), Thyroid stimulating hormone (TSH) and Immunoglobulin E(IgE).
Results: ASST was positive in 44.8% out of 58 patients. ASST positive patients showed longer disease duration, higher severity and more generalised disease than the negative group. AEC was relatively lower, although statistically insignificant in ASST positive patients (284.21±57.43 cells/ul) as compared to AEC in ASST negative patients (310.64±71.05 cells/ul) (p=0.131). TSH on the other hand showed comparable values in both the groups (p=0.744). Mean serum IgE showed statistically significant difference between those who were ASST positive (297.96 ±42.34 IU/ml) vs ASST negative. (323.57 ±44.16 IU/ml) (p=0.029*).
Conclusions: ASST can serve as a useful test to diagnose patients with autoimmune urticaria which can often be more severe and prolonged as well as being refractory to conventional treatment. Lower values of AEC and IgE in ASST positive patients may complement the diagnosis of autoimmune urticaria.
Keywords: Chronic Spontaneous Urticaria, Autoimmune, ASST, IgE, AEC
How to cite : Mir M M, Autologous serum skin test in chronic spontaneous urticaria and its correlation with biochemical markers- A descriptive study from a tertiary hospital of North India. IP Indian J Clin Exp Dermatol 2022;8(3):147-151
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Received : 29-06-2022
Accepted : 25-07-2022
Viewed: 887
PDF Downloaded: 188